August 20, 2009 / 6:33 AM / 11 years ago

UPDATE 1-ProStrakan H1 product sales up by over a third

* Pretax loss narrows to 9.4 mln stg compared with 11.8 mln

* Says on track to break even in 2009 (Adds details)

LONDON, Aug 20 (Reuters) - British speciality pharmaceutical company ProStrakan PSK.L said on Thursday that first-half product sales rose by over a third, leaving it on track to meet its goal of breaking even this year.

The company, which markets drugs to treat a range of conditions including age-related diseases and cancer, booked a first-half pretax loss for the six months to June 30 narrowing to 9.4 million pounds ($15.48 million) compared with 11.8 million last time.

It reported product sales for the period up 36 percent to 34.6 million pounds.

(Reporting by Ben Deighton; Editing by Tom Freke)

$1=.6073 Pound

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below